{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:06:46Z","timestamp":1792429606659,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.3129\/i07-190","type":"journal-article","created":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T13:28:42Z","timestamp":1207747722000},"page":"79-83","source":"Crossref","is-referenced-by-count":15,"title":["Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid"],"prefix":"10.1016","volume":"43","author":[{"given":"Mohammad S.","family":"Farahvash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh Moradi","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3129\/i07-190_bib1","article-title":"Venous occlusive disease of retina","volume":"3","author":"Sanborn","year":"1996"},{"key":"10.3129\/i07-190_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bjo.84.6.609","article-title":"Treatment of recent onset central retinal vein occlusion with intravitreal TPA: a pilot study","volume":"84","author":"Glacet-Bernard","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i07-190_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00417-001-0388-0","article-title":"Effect of isovolemic hemodilution in central retinal vein occlusion","volume":"239","author":"Glacet-Bernard","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.3129\/i07-190_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1034\/j.1600-0420.1999.770604.x","article-title":"Protein C, protein S and antithrombin 3 deficiencies in retinal vein occlusion","volume":"77","author":"Tekeli","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.3129\/i07-190_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(82)34655-2","article-title":"Retinal ischemia and risk of neovascularization following CRVO","volume":"89","author":"Magargal","year":"1982","journal-title":"Ophthalmology"},{"key":"10.3129\/i07-190_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1034\/j.1600-0420.1999.770606.x","article-title":"Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion","volume":"77","author":"Larsson","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.3129\/i07-190_bib7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0002-9394(03)00571-3","article-title":"Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12) and thermo-labile MTHFR genotype as risk factors for retinal vascular occlusive disease","volume":"136","author":"Cahill","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i07-190_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00417-001-0421-3","article-title":"Hematologic abnormalities associated with various types of retinal vein occlusion","volume":"240","author":"Hayreh","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.3129\/i07-190_bib9","first-page":"90484","article-title":"The management of central retinal vein occlusion","author":"Kohner","year":"1983","journal-title":"Ophthalmology"},{"key":"10.3129\/i07-190_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9394(14)75791-5","article-title":"A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin","volume":"118","author":"Glacet-Bernard","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i07-190_bib11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/bjo.83.10.1194c","article-title":"Acute central retinal vein occlusion successfully treated with intravenous thrombolysis","volume":"83","author":"Costen","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i07-190_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00006982-200510000-00005","article-title":"Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion","volume":"25","author":"Cekic","year":"2005","journal-title":"Retina"},{"key":"10.3129\/i07-190_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.122.8.1137","article-title":"Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion","volume":"122","author":"Bashshur","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i07-190_bib14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00006982-200312000-00006","article-title":"Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion","volume":"23","author":"Ghazi","year":"2003","journal-title":"Retina"},{"key":"10.3129\/i07-190_bib15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archopht.121.10.1385","article-title":"Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion","volume":"121","author":"Garcia-Arumi","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i07-190_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/bjo.87.8.1043","article-title":"Laser induced chori-oretinal venous anastomosis in ischaemic central retinal vein occlusion","volume":"87","author":"Kwok","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i07-190_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00417-004-1046-0","article-title":"Vitrectomy and radial optic neurotomy for central retinal vein occlusion: effects on visual acuity and macular anatomy","volume":"243","author":"Zambarakji","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.3129\/i07-190_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2006.12.037","article-title":"Clinical, anatomic, and electro-physiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion","volume":"143","author":"Pai","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i07-190_bib19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archopht.1957.00940010834004","article-title":"Experience of treating retinal venous occlusion with anticoagulant and antisclerotic therapy","volume":"58","author":"Vannas","year":"1957","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i07-190_bib20","first-page":"758","article-title":"Anticoagulant, fibrinolytic and antiplatelet therapy","volume":"1","author":"Handin","year":"2001"},{"key":"10.3129\/i07-190_bib21","first-page":"119","article-title":"Antithrombotic therapy","volume":"1","author":"Harker","year":"2000"},{"key":"10.3129\/i07-190_bib22","first-page":"451","article-title":"Evaluation of fraxiparine efficacy in the treatment of retinal vein occlusion","volume":"101","author":"Romanowska","year":"1999","journal-title":"Klin Oczna"},{"key":"10.3129\/i07-190_bib23","first-page":"21","article-title":"Results of fraxiparin and ticlid therapy of acute retinal vessel occlusion","volume":"114","author":"Kasymova","year":"1998","journal-title":"Vestnik Oftalmologi"},{"key":"10.3129\/i07-190_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM199203193261205","article-title":"Molecular and cellular biology of blood coagulation","volume":"326","author":"Furie","year":"1992","journal-title":"N Engl J Med"},{"key":"10.3129\/i07-190_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","article-title":"Heparin","volume":"324","author":"Hirsh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.3129\/i07-190_bib26","first-page":"44","article-title":"Dalteparin versus aspirin in recent-onset central retinal vein occlusion","volume":"16","author":"Farahvash","year":"2004","journal-title":"Iran J Ophthalmol"},{"key":"10.3129\/i07-190_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0161-6420(83)34530-9","article-title":"Classification of central retinal vein occlusion","volume":"90","author":"Hayreh","year":"1983","journal-title":"Ophthalmology"},{"key":"10.3129\/i07-190_bib28","first-page":"1041","article-title":"Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion","volume":"290","author":"Kilgore","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3129\/i07-190_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0022-5223(98)70288-0","article-title":"Heparin and nonanti-coagulant heparin preserve regional myocardial contractility after ischemia-reperfusion injury. Role of nitric oxide","volume":"115","author":"Kouretas","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.3129\/i07-190_bib30","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.106.642074","article-title":"A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement","volume":"114","author":"Eriksson","year":"2006","journal-title":"Circulation"},{"key":"10.3129\/i07-190_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/CIRCULATIONAHA.106.664169","article-title":"The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy","volume":"114","author":"Mahaffey","year":"2006","journal-title":"Circulation"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418208800476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418208800476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:47:11Z","timestamp":1542707231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418208800476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0008418208800476"],"URL":"https:\/\/doi.org\/10.3129\/i07-190","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}